Standard BioTools
LAB
LAB
98 hedge funds and large institutions have $182M invested in Standard BioTools in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
64% less call options, than puts
Call options by funds: $126K | Put options by funds: $349K
Holders
98
Holding in Top 10
–
Calls
$126K
Puts
$349K
Top Buyers
| 1 | +$4.81M | |
| 2 | +$2.64M | |
| 3 | +$2.06M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$1.84M |
| 5 |
Millennium Management
New York
|
+$1.16M |
Top Sellers
| 1 | -$16M | |
| 2 | -$2.32M | |
| 3 | -$1.59M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.35M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$489K |